Background: Major congenital malformations place a considerable burden on the affected child, the family and society. Any kind of medicine used during pregnancy might have a harmful impact; therefore, such practice has raised concerns. The objective of the current study was to explore the relationship between the use of herbal medicines by pregnant women during the first trimester of pregnancy and the risk of major congenital malformation in their live born infants.
Methods: This was a cross-sectional analysis of data from a prospective pregnancy cohort, which was established between 1984 and 1987. To assemble the cohort, pregnant women of ≥26 weeks of gestation who came to the Taipei Municipal Maternal and Child Hospital in Taiwan for prenatal care were enrolled in the study and interviewed using a structured questionnaire. Detailed information, including herbal medicine use during different periods of pregnancy, was obtained during the interview. Past medical history, current obstetric data and details on conventional medicines used during pregnancy were abstracted from medical records. Data on birth weight, gestational duration and characteristics of live born infants were gathered from the Taiwan national birth register. Congenital malformation information was obtained from multiple sources: the newborn examination record (1984–7); the national death register (1984–2003); and Taiwan National Health Insurance data (1996–2000). Multiple logistic regression was used to estimate the odds ratio [OR] of major congenital malformation by herbal medicines used during the first trimester.
Results: A total of 14 551 live births were analysed. After adjustment for confounding factors, taking huanglian during the first trimester of pregnancy was found to be associated with increased risk of congenital malformations of the nervous system (adjusted OR 8.62, 95% CI 2.54, 29.24). An-Tai-Yin was associated with an increased risk of congenital malformations of the musculoskeletal and connective tissues (adjusted OR 1.61, 95% CI 1.10, 2.36) and the eye (adjusted OR 7.30, 95% CI 1.47, 36.18).
Conclusion: We found evidence for a possible link between the use of specific herbal medicines during the first trimester of pregnancy and increased risks of specific groups of congenital malformations. We could not investigate whether the adverse effects were related to direct toxicity from the herbal medicines, or were from misuse, contamination or uncontrolled confounding. Nonetheless, we would advise caution regarding use of herbal medicines during pregnancy, and we suggest that further investigation of these findings is warranted.
Pregnant Woman Herbal Medicine Prenatal Care Congenital Malformation Berberine
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
This study was supported by grants (BHP-PHRC-92-4 and D0H93-HP-1702) from the Bureau of Health Promotion, Department of Health, Taiwan.
The authors have no conflicts of interest that are directly relevant to the content of this study.
Anthony S, Kateman H, Brand R, et al. Ethnic differences in congenital malformations in the Netherlands: analyses of a 5-year birth cohort. Paediatr Perinat Epidemiol 2005; 19: 135–44PubMedCrossRefGoogle Scholar
Kalter H. Teratology in the 20th century: environmental causes of congenital malformations in human and how they were established. Neurotoxicol Teratol 2003; 25: 131–282PubMedCrossRefGoogle Scholar
Hoffmann W. Fallout from the Chernobyl nuclear disaster and congenital malformations in Europe. Arch Environ Health 2001; 56: 478–84PubMedCrossRefGoogle Scholar
Mone SM, Gillman MW, Miller TL, et al. Effects of environmental exposures on the cardiovascular system: prenatal period through adolescence. Pediatrics 2004; 113: 1058–69PubMedGoogle Scholar
Li SJ, Ford N, Meister K, et al. Increased risk of birth defects among children from multiple births. Birth Defects Res A Clin Mol Teratol 2003; 67: 879–85PubMedCrossRefGoogle Scholar
Becker SM, Al Halees Z, Molina C, et al. Consanguinity and congenital heart disease in Saudi Arabia. Am J Med Genet 2001; 99: 8–13PubMedCrossRefGoogle Scholar
Rasmussen SA, Moore CA, Paulozzi LJ, et al. Risk for birth defects among premature infants: a population-based study. J Pediatr 2001; 138: 668–73PubMedCrossRefGoogle Scholar
Chuang CH, Lai JN, Wang JD, et al. Prevalence and related factors of Chinese herbal medicine use in pregnant women of Taipei, 1985-1987. Taiwan J Public Health 2005; 24: 335–47Google Scholar
Chuang CH, Lai JN, Wang JD, et al. Use of coptidis rhizoma and foetal growth: a follow-up study of 9895 pregnancies. Pharmacoepidemiol Drug Saf 2006; 15: 185–92PubMedCrossRefGoogle Scholar
Goldbeck-Wood S, Dorozynski A, Lie LG, et al. Complementary medicine is booming worldwide. BMJ 1996; 313: 131–3CrossRefGoogle Scholar
Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280: 1569–75PubMedCrossRefGoogle Scholar
Ni H, Simile C, Hardy AM. Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey. Med Care 2002; 40: 353–8PubMedCrossRefGoogle Scholar
Nordeng H, Havnen GC. Impact of socio-demographic factors, knowledge and attitude on the use of herbal drugs in pregnancy. Acta Obstet Gynecol Scand 2005; 84: 26–33PubMedGoogle Scholar
Nordeng H, Havnen GC. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiol Drug Saf 2004; 13: 371–80PubMedCrossRefGoogle Scholar
Tiran D. The use of herbs by pregnant and childbearing women: a risk-benefit assessment. Complement Ther Nurs Midwifery 2003; 9: 176–81PubMedCrossRefGoogle Scholar
Tsui B, Dennehy CE, Tsourounis C. A survey of dietary supplement use during pregnancy at an academic medical center. Am J Obstet Gynecol 2001; 185: 433–7PubMedCrossRefGoogle Scholar
Gibson PS, Powrie R, Star J. Herbal and alternative medicine use during pregnancy: a cross-sectional survey. Obstet Gynecol 2001; 97Suppl. 1: S44–5Google Scholar
Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systemic review. J Intern Med 2002; 252: 107–13PubMedCrossRefGoogle Scholar
World Health Organization. WHO traditional medicine strategy 2002-2005. Geneva: World Health Organization, 2002 (document reference WH0/TRM/2002.1)Google Scholar
World Health Organization. General guidelines for methodologies on research and evaluation of traditional medicines. Geneva: World Health Organization, 2000: 27 (document reference WH0/EDM/TRM/2000.1)Google Scholar
Eurocat. Eurocat guide 1.2: instructions for the registration of congenital anomalies. Northern Ireland: Eurocat Central Registry, 2002Google Scholar
Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993; 138: 923–36PubMedGoogle Scholar
Directorate-General of Budget, Accounting & Statistics. Manpower statistic annual report, 2004. Census Bureau, Directorate-General of Budget, Accounting & Statistics (DGBAS), Taiwan, 1985-7 [online] [in Chinese]. Available from URL: http://www.dgbas.gov.tw/census~n/four/yrtable4,5,13.xls [Accessed 2005 Jan 1]Google Scholar
Chen PC, Fu WL, Wang TR. Congenital malformation statistics in Taiwan, 1993. Taipei, Taiwan: Department of Health, The Excusive Yuan/National Taiwan University Hospital, 1995Google Scholar
Vaughan Jones SA, Hern S, Nelson-Piercy C, et al. A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles. Br J Dermatol 1999; 141: 71–81PubMedCrossRefGoogle Scholar
Fu Q-Z, Yang S-Z, Liu D-W. Fu Qing-zhus gynecology. Boulder, (CO): Blue Poppy Press, 1999Google Scholar
Wen KC. The turnover rate of marker constituents in Chinese herbal medicines. J Food Drug Anal 2000; 8: 270–7Google Scholar